Barclays PLC Anixa Biosciences Inc Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$3.57 - $5.6 $9,039 - $14,179	-2,532 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$3.46 - $4.92 $25,832 - $36,732	-7,466 Reduced 74.67%	2,532 $10,000
Q1 2021 May 13, 2021	BUY	$3.27 - $7.14 $32,693 - $71,385	9,998 New	9,998 $47,000
Q1 2020 May 13, 2020	SELL	$1.35 - $4.06 $1 - $4	-1 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$2.78 - $4.03 $2 - $4	1 New	1 $0

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $107M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.